Investor's Business Daily on MSN11h
Does AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol?
AstraZeneca said Monday its experimental pill lowered "bad" LDL cholesterol by 51%. The results showed promise again rival drugs from Merck and NewAmsterdam Pharma, but AstraZeneca stock fell in line ...
Medscape12y
LDL Lowering in Peripheral Arterial Disease
[27] If patients do not reach LDL goals with diet and exercise ... these occur in a minority of the entire population of patients with claudication. Role of Lowering LDL-C in PAD There are ...
Medscape2d
Effectiveness and Tolerability of Every-Other-Day Rosuvastatin Dosing in Patients with Prior Statin Intolerance
Dosing a statin (rosuvastatin) every other day (EOD) may provide significant lipoprotein changes while avoiding common adverse effects in this statin-intolerant population. Objective: To determine ...